Meeting Protein Targets in Critically Ill Patients

NCT ID: NCT03319836

Last Updated: 2018-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-04

Study Completion Date

2018-02-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective study of protein and energy intake in enterally fed critically ill adult patients before and after the introduction of a very high protein enteral nutrition formula in a single center medical/surgical ICU.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Dietary Modification

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-very high protein enteral nutrition

20 enterally fed critically ill adult patients prior to the introduction of a very high protein enteral nutrition formula \[2015\].

No interventions assigned to this group

Post-very high protein enteral nutrition

20 enterally fed critically ill adult patients post the introduction of a very high protein enteral nutrition formula \[2016\].

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients ≥ 18 years of age, mechanically ventilated
* Received enteral nutrition for a minimum of five days during the first week of ICU admission

Exclusion Criteria

* Received parenteral nutrition during first week of ICU admission
* Acute renal failure not dialyzed
* Hepatic encephalopathy grade 3 or 4
* Intentional underfeeding/trophic feeding - including refeeding syndrome
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hamilton Health Sciences Corporation

OTHER

Sponsor Role collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michele ApSimon

Role: PRINCIPAL_INVESTIGATOR

Hamilton Health Sciences Centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hamilton Health Sciences

Hamilton, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16.02.CA.HCN

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Basel Enteral High Protein Study
NCT02678325 TERMINATED NA
Amino Acid Nutrition in the Critically-ill
NCT02865408 ACTIVE_NOT_RECRUITING NA